Introduction: Since 2008, new oral anticoagulants (NOACs) have been approved for the
prevention of venous thromboembolism (VTE) in patients receiving hip or knee replacement …

Patients taking direct oral anticoagulants (DOACs) who then need an emergency invasive
procedure require specialized management strategies. Appropriate patient evaluation …

Atrial fibrillation (AF) is the most common arrhythmia in clinical practice and its prevalence
increases with age. Few data are available about the clinical performance of direct oral …

Atrial fibrillation (AF) is the most common arrhythmia, ranging from 0.1% in patients< 55
years to> 9% in octogenarian patients. One important issue is represented by the 5-fold …

Atrial fibrillation is the most common cardiac arrhythmia and is associated with an increased
risk of stroke and thromboembolic complications. A rhythm control strategy with both …

This observational study aimed to investigate the efficacy and safety of non–vitamin K
antagonist oral anticoagulants (NOACs) in atrial fibrillation (AF) patients with malignancy. A …

Nonvitamin K oral anticoagulants (NOACs) sometimes cause hemorrhage, and the
gastrointestinal tract is a common site of involvement. However, clinical characteristics of …

This is an observational study to investigate the efficacy and safety of nonvitamin K
antagonist oral anticoagulants (NOACs) in atrial fibrillation (AF) patients with bioprosthetic …

The aim of our article is to provide a concise review for clinicians entailing the main studies
that evaluated the efficacy and safety of target-specific oral anticoagulants (TSOAs) for …

Background Octogenarian patients are at high risk of both ischaemic and bleeding events,
and the low body weight is considered a risk factor for major bleeding in atrial fibrillation (AF) …